On the inefficiency of the adaptive design for monitoring clinical trials
From MaRDI portal
Publication:4455417
Recommendations
- scientific article; zbMATH DE number 1361706
- Some recent developments in the design of adaptive clinical trials
- Adaptive design methods in clinical trials
- Adaptive designs for noninferiority trials
- Some optimal adaptive designs in clinical trials
- On the efficiency of adaptive designs for flexible interim decisions in clinical trials
- An adaptive design for multi-arm clinical trials
- Optimal adaptive randomized designs for clinical trials
Cited in
(20)- Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials
- Bandit Theory: Applications to Learning Healthcare Systems and Clinical Trials
- Benefit–Risk Evaluation of Multi-Stage Adaptive Designs
- Statistical Inference for Self‐Designing Clinical Trials with a One‐Sided Hypothesis
- Adaptive and nonadaptive group sequential tests
- Sample size adaptation designs and efficiency comparison with group sequential designs
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs
- Monitoring Accumulating Data in a Clinical Trial
- On the efficiency of adaptive designs for flexible interim decisions in clinical trials
- On the efficiency of adaptive sample size design
- Optimal planning of adaptive two-stage designs
- Adaptive randomized trial designs that cannot be dominated by any standard design at the same total sample size
- Sample size re-estimation for confirmatory two-stage flexible multi-arm trial with normal outcomes
- Optimal adaptive promising zone designs
- Internal pilots for observational studies
- Are Flexible Designs Sound?
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
- Flexible Designs for Genomewide Association Studies
- Designing a longitudinal clinical trial based on a composite endpoint: sample size, monitoring, and adaptation
- α-Investing: a Procedure for Sequential Control of Expected False Discoveries
This page was built for publication: On the inefficiency of the adaptive design for monitoring clinical trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4455417)